Menera Capsule
NDC Package 84761-0004-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Menera capsules is medicinal Technologies MEnera Personal care should always begin with pure ingredients, and that's the concept behind the products of Medicinal Technologies. This formulation utilizes a capsule delivery system. Marketed by Tejeda Enterprises Incorporated, this product is identified by NDC 84761-0004 and is authorized under FDA application M027.

Identification & Billing

NDC Package Code
84761-0004-1
Package Description
60 U in 1 CAPSULE
Product Code
84761-0004
11-Digit Billing Format
84761000401

Clinical Specifications

Proprietary Name
Menera
Non-Proprietary Name
Menera
Substance Name
Allicin; Lepidium Meyenii Root; Ubiquinol
Dosage Form
Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Medicinal Technologies MEnera Personal care should always begin with pure ingredients, and that's the concept behind the products of Medicinal Technologies. We focus on the development of biomedical remedies to address the source of ailments on a cellular level. We pride ourselves in the care and time that is taken for the creation of each individual product, keeping in mind the health and welfare of all. We use no artificial days, parabens, DEA'S, fragrances, Preservatives or phthalates. DOCTOR RECOMMENDED MEnera Balance reproductive hormones Ease menopausal symptoms Regulate menstrual cycles • Improve fertility Medicinal Technologies CLINICALLY PROVEN 60 Capsules

Regulatory & Marketing

Labeler Name
Tejeda Enterprises Incorporated
Product Type
Human Otc Drug
FDA Application #
M027
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
10-01-2024
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 84761-0004-1 identifies a specific commercial package of 60 u in 1 capsule of Menera, a human over the counter drug labeled by Tejeda Enterprises Incorporated. This capsule is formulated for oral use and contains allicin; lepidium meyenii root; ubiquinol as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Tejeda Enterprises Incorporated on October 01, 2024. The current certification is valid through December 31, 2026.

How is this Tejeda Enterprises Incorporated product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 84761000401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
84761-0004-1
11-Digit CMS (5-4-2)
84761-0004-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.